𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-PCSK9 Antibody Effectively Lowers Cholesterol in Patients With Statin Intolerance

✍ Scribed by Stroes, Erik; Colquhoun, David; Sullivan, David; Civeira, Fernando; Rosenson, Robert S.; Watts, Gerald F.; Bruckert, Eric; Cho, Leslie; Dent, Ricardo; Knusel, Beat; Xue, Allen; Scott, Rob; Wasserman, Scott M.; Rocco, Michael


Book ID
122183693
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
196 KB
Volume
63
Category
Article
ISSN
1558-3597

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effect of a Monoclonal Antibody to PCSK9
✍ Sullivan, David; Olsson, Anders G.; Scott, Rob; Kim, Jae B.; Xue, Allen; Gebski, πŸ“‚ Article πŸ“… 2012 πŸ› American Medical Association 🌐 English βš– 290 KB

## Context: An estimated 10% to 20% of patients cannot tolerate statins or adequate doses to achieve treatment goals. plasma proprotein convertase subtilisin/kexin type 9 (pcsk9) binds to low-density lipoprotein (ldl) receptors, promoting their degradation and increasing ldl cholesterol levels. in